Sickle cells

#Sickle cells #Sub-Saharan Africa

African initiative to support sickle cell disease care 

A regional initiative has been launched across Africa to help countries strengthen sickle cell disease care.  The Imara Sickle Cell Framework, led by African health leaders and partners, is designed to translate policy priorities into practical, coordinated care delivery within national health systems.  Initial implementation… Read More

#News

Sickle cells
#Beam Therapeutics #Genetic diseases #Sickle cells

Beam expands liver-targeted genetic disease programme 

Biotechnology company Beam Therapeutics is set to expand its liver-targeted genetic disease franchise for the treatment of phenylketonuria (PKU).  Beam’s lead programme, BEAM-304, leverages the company’s proprietary and clinically validated base editing technology and lipid nanoparticle (LNP) delivery capabilities to directly and durably correct mutations in the phenylalanine… Read More

#News

Sickle cells
#GlobalData #Sickle cells #Therapeutics

How US sickle cell disease market will reach $4.8 billion by 2030 

A number of new sickle cell disease (SCD) drugs are set to hit the US market, says GlobalData, including gene therapies that could offer patients a cure.   The cause of the increase  GlobalData notes that one of the gene therapies that is currently closest to… Read More

#News